Previous 10 | Next 10 |
Recent news releases related news releases and press releases from 11/07/23 07:09:14 on US and Canada Markets.
Revenues G rew 6% to $63.9 million ; GAAP Operating Income of $12.7 million and A djusted EBITDA of $9.5 million, 30% Growth Y ear-over- Y ear ; PETAH TIKVA, Israel, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Gilat Sat...
CHICAGO, IL - ( NewMediaWire ) - November 07, 2023 - Epazz, Inc. (OTC: EPAZ), A mission-critical provider of drone technology, artificial intelligence software, cryptocurrency apps, blockchain mobile apps, and cloud-based business software solutions, has exciting news to share today. Epazz,...
~ Announced FDA clearance of Investigational New Drug (IND) application for AMT-260 in refractory mesial temporal lobe epilepsy ~ ~ On track to provide clinical update from U.S. and European Phase I/II trials of AMT-130 in Huntington’s disease later in the fourth quarter ...
Cloud-based Universal ZTNA to offer network access control, access point and switch security within a single solution, creating a frictionless user experience and consistent security policy Extreme Networks™, Inc. (Nasdaq: EXTR), a leader in cloud networking, today introduced...
VANCOUVER, BC / ACCESSWIRE / November 7, 2023 / Aton Resources Inc. (TSXV:AAN) ("Aton" or the "Company") is pleased to update investors on the latest results from the recent reverse circulation percussion ("RC") drilling at the Semna prospect, located within its 100% owned Abu Marawat Concession...
ZTALMY ® (ganaxolone) Q3 net product revenue of $5.4 million; 2023 net product revenue guidance increased to between $18.5 and $19 million Over 75% of patients required for the interim analysis are now enrolled in the Phase 3 RAISE trial in refractory status epilepticus; if the trial...
Gogo Announces Third Quarter Results PR Newswire Updates 2023 Financial Guidance and Reiterates Long-Term Targets Total Revenue of $97.9 million , down 7% Year-over-Year; Record Third Quarter Service Revenue of $79.5 million , up 6% Year-over-Year ...
Financial Overview - Third Quarter Revenues of $139 Million, Down 4% From a Year Ago Adjusted Operating Income Margin of 8.5%, GAAP Operating Loss Margin of (19.2)% Adjusted EPS of $0.12; GAAP Diluted EPS of $(0.27) Financial Overview - Nine Months Revenues of $4...
LONDON and SALT LAKE CITY, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that it will report its first quarter fiscal year 2024 financial results on Tuesday, November 14, 2023, before market open. The Company will host a corresponding conference call and liv...
Advancing dose escalation portion of Phase 1 clinical trial of XMT-1660, Mersana’s B7-H4 Dolasynthen ADC Preparations underway to resume enrollment in Phase 1 clinical trial of XMT-2056, Mersana’s HER2 Immunosynthen ADC Capital resources expected to support current o...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
25.97%Change Percent:
LogicMark Inc Com Par$ (New) Company Name:
LGMK Stock Symbol:
NASDAQ Market:
logicmark.com Website: